DURECT Corporation (NASDAQ: DRRX) today announced a patent purchase agreement with Indivior UK Limited, whereby DURECT has assigned certain ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE